Global Cell Therapy Market—Companies to Action, 2018
Global Cell Therapy Market—Companies to Action, 2018
A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth
11-Mar-2019
North America
$3,000.00
Special Price $2,250.00 save 25 %
Description
The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule therapies, with cell therapies dominating the space. The study on the "Global Cell Therapy Market, 2018, Companies to Action” presents an overview of the global cell therapy landscape, with an emphasis on the key game-changing companies disrupting this market. The study highlights the emerging companies across regions that support the development and manufacturing of novel cell therapies.
With the changing market landscape, big pharma and biopharma participants, are looking toward the adoption of a collaborative business approach by either entering into co-development and/or co-commercialization agreements or acquiring smaller, niche participants so as to achieve a competitive advantage with respect to a specific therapy area or technology. The study also delves into some of the leading strategies adopted by market participants in order to succeed in this highly dynamic market. In addition to the above-mentioned strategic analysis, information such as risk sharing and fast to market business models of some of the emerging business models across the cell therapy market is also provided.
Research Highlights
This study identifies some of the strategies adopted by these game-changing companies with respect to key market-growth opportunities such as the use of combination therapies, manufacturing advancement and automation, adoption of newer gene-editing technologies such as CRISPR/Cas9, and so on. The study also highlights some collaborations and partnerships between these disruptive participants and throws some light on their upcoming drug pipeline; thereby, highlighting their contribution to this market. Additionally, it gives an insight into the leading strategic imperatives shaping the global industry and its long-term implication on market growth.
Key Issues Addressed
- What are the key market opportunities in the global cell therapy market?
- What is the impact of external industry environment on market growth?
- Which are some of the unique participants that are introducing cutting-edge therapies in this segment?
- What are the strategic imperatives to be adopted by these participants to bring about this market transformation?
- What is the growth potential of this rapidly expanding cell therapy market?
- What are some key factors for success in the global cell therapy market?
Table of Contents
Key Findings—Analysis of Companies to Action
Key Findings—Analysis of Companies to Action (continued)
Scope and Segmentation
Key Questions Addressed in this Study
Companies to Action Value Creators
Opportunities and Threats
Market Definitions
Market Segmentation
Cell Therapy Value Chain
Vendor Ecosystem
Impact of Key Market Influencers
Top 3 Trends and Vendor Strategies
Key Market Participants Aligned with Top 3 Trends
Cell Therapy—Vendor Landscape
Juno Therapeutics—Overview
Juno Therapeutics—Technology Platforms
Juno Therapeutics—Major Partnerships and Agreements
bluebird bio—Business Overview
bluebird bio—Technology Platform
bluebird bio—Major Partnerships and Agreements
Kite Pharma—Overview
Kite Pharma—Key Technology/ Product/Services
Kite Pharma—Case Example and Recent Developments
Adaptimmune—Overview
Adaptimmune—Technology Platforms
Adaptimmune—Case Example and Recent Developments
Oxford BioMedica—Overview
Oxford BioMedica—Technology Platform
Oxford BioMedica—Case Example and Recent Developments
JCR Pharmaceuticals—Overview
JCR Pharmaceuticals—Technology Platforms
JCR Pharmaceuticals—Case Example and Recent Developments
Sangamo Therapeutics—Company Overview
Sangamo Therapeutics—Value Proposition
DiscGenics—Company Overview
DiscGenics—Value Proposition
TiGenix—Company Overview
TiGenix—Value Proposition
Bone Therapeutics—Company Overview
Bone Therapeutics—Value Proposition
Cell Medica—Company Overview
Cell Medica—Value Proposition
Mesoblast—Company Overview
Mesoblast—Value Proposition
Cynata Therapeutics—Company Overview
Cynata Therapeutics—Value Proposition
Medipost—Company Overview
Medipost—Value Proposition
Anterogen—Company Overview
Anterogen—Value Proposition
Pharmicell—Company Overview
Pharmicell—Value Proposition
Short Profiles of Digital Pathology Companies
Short Profiles of Digital Pathology Companies (continued)
Short Profiles of Digital Pathology Companies (continued)
Short Profiles of Digital Pathology Companies (continued)
Transformation in the Industry Ecosystem
Five Major Growth Opportunities
Strategic Imperatives for Growth
Conclusion—Key Takeaways
Legal Disclaimer
Abbreviation List
List of Exhibits
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
Research Highlights
This study identifies some of the strategies adopted by these game-changing companies with respect to key market-growth opportunities such as the use of combination therapies, manufacturing advancement and automation, adoption of newer gene-editing technologies such as CRISPR/Cas9, and so on. The study also highlights some collaborations and partnerships between these disruptive participants and throws some light on their upcoming drug pipeline; thereby, highlighting their contribution to this market. Additionally, it gives an insight into the leading strategic imperatives shaping the global industry and its long-term implication on market growth.
Key Issues Addressed
- What are the key market opportunities in the global cell therapy market?
- What is the impact of external industry environment on market growth?
- Which are some of the unique participants that are introducing cutting-edge therapies in this segment?
- What are the strategic imperatives to be adopted by these participants to bring about this market transformation?
- What is the growth potential of this rapidly expanding cell therapy market?
- What are some key factors for success in the global cell therapy market?
No Index | No |
---|---|
Podcast | No |
Author | Aarti Chitale |
Industries | Healthcare |
WIP Number | PA16-01-00-00-00 |
Is Prebook | No |
GPS Codes | 9600-B1,9571-B1,99C1-B1,9568-B1,9611-B1 |